Abstract
The role of estrogen in lordosis-inhibiting systems in the lateral septum or the dorsal raphe nucleus was investigated in female and male rats. Ovariectomized rats received implantation of 22-gauge guide cannulae to the bilateral or right side of the lateral septum (LS and rLS, respectively), the dorsal raphe nucleus (DRN) or bilateral cortex (CX). In castrated male rats, bilateral implantations of the cannulae to the LS were carried out (mLS). Three behavioral tests in total were performed at 2-week intervals. In the first test, all animals were subcutaneously injected with 1.5 µg/kg estradiol benzoate (EB). Forty-four hours after EB, 0.5 mg progesterone (P) was injected and a behavioral test was started 4 h after P. These hormonal regimes were used in all tests. In the second test, 2 h before EB injection, 27-gauge cannulae filled with estradiol (E2) were inserted into the DRN, LS or CX through the guide cannulae and were kept there for 4 h. In the third test, cholesterol was implanted instead of E2 into these areas. In the first test, most females showed low levels of lordosis quotient (LQ) and most males showed no lordosis. In the second test, mean LQs in the LS or rLS groups of females increased but not in the DRN and CX groups. In the mLS group no increase of LQ was observed. When cholesterol was implanted in the third test, mean LQs in all groups were as low as in the first test. These results suggest the possibility that estrogen releases the inhibition when it acts on the LS, but not on the DRN female rats. On the other hand, inhibition in the male LS may not be released by the direct action of estrogen.
References
1.
Pfaff DW, Schwartz-Giblin S, McCarthy MM: Cellular and molecular mechanisms of female reproductive behaviors; in Knobil E, Neill JD (eds): The Physiology of Reproduction, ed 2. New York, Raven Press, 1994, pp 107–220.
2.
Mathews D, Edwards DA: Involvement of the ventromedial and anterior hypothalamic nuclei in the hormonal induction of receptivity in the female rat. Physiol Behav 1977;19:319–326.
3.
Rajendren G, Dudley CA: Moss RL: Role of ventromedial nucleus of hypothalamus in the male-induced enhancement of lordosis in female rats. Physiol Behav 1991;50:705–710.
4.
Pfaff DW, Sakuma Y: Facilitation of the lordosis reflex of female rats from the ventromedial nucleus of the hypothalamus. J Physiol 1979;288:189–202.
5.
Micevych PE, Matt DW, Go VLW: Concentration of cholecystokinin, substance P, and bombesin in discrete regions of male and female rat brain: Sex differences and estrogen effects. Exp Neurol 1988;100:416–425.
6.
Luine VN, Grattan DR, Selmanoff M: Gonadal hormones alter hypothalamic GABA and glutamate levels. Brain Res 1997;747:165–168.
7.
Shughrue PJ, Lane MV, Merchenthaler I: Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 1997;388:507–525.
8.
Blaustein JD: Estrogen receptor immunoreactivity in rat brain: Rapid effects of estradiol injection. Endocrinology 1993;132:1218–1224.
9.
Barfield RJ, Chen JJ: Activation of estrous behavior in ovariectomized rats by intracerebral implants of estradiol benzoate. Endocrinology 1977;101:1716–1725.
10.
Okada R, Watanabe H, Yamanouchi K, Arai Y: Recovery of sexual receptivity in female rats with lesions of the ventromedial hypothalamus. Exp Neurol 1980;68:595–600.
11.
Yamanouchi K: Brain mechanisms inhibiting the expression of heterotypical sexual behavior in rats; in Maeda KI, Tsukamura H, Yokohama A (eds): Neural Control of Reproduction – Physiology and Behavior. Tokyo, Japan Scientific Society Press, 1997, pp 291–235.
12.
Yamanouchi K, Arai Y: The septum as origin of a lordosis-inhibiting influence in female rats: Effect of neural transection. Physiol Behav 1990;48:351–355.
13.
Nance DW, Shryne J, Gorski RA: Septal lesions: Effects on lordosis behavior and pattern of gonadotropin release. Horm Behav 1974;5:73–81.
14.
Zasorin NL, Malsburgy CW, Pfaff DW: Suppression of lordosis in the hormone-primed female hamster by electrical stimulation of the septal area. Physiol Behav 1975;14:595–599.
15.
Kondo Y, Shinoda A, Yamanouchi K, Arai Y: Role of septum and preoptic area in regulating masculine and feminine sexual behaviors in male rats. Horm Behav 1990;24:421–434.
16.
Nance DM, Shryne J, Gorski RA: Facilitation of female sexual behavior in male rats by septal lesions: An interaction with estrogen. Horm Behav 1975;6:289–299.
17.
Simerly RB, Chang C, Muramatsu M, Swanson LW: Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: An in situ hybridization study. J Comp Neurol 1990;294:76–95.
18.
Erskine MS, MacLusky NJ, Baum MJ: Effect of 5-alpha-dihydrotestosterone on sexual receptivity and neural progestin receptors in ovariectomized rats given pulsed estradiol. Biol Reprod 1985;33:551–559.
19.
Tobet SA, Baum MJ: Implantation of dihydrotestosterone propionate into the lateral septum inhibits sexual receptivity in estrogen-primed, ovariectomized rats. Neuroendocrinology 1982;34:333–338.
20.
Yamanouchi K, Arai Y: The role of mesencephalic tegmentum in regulating female rat sexual behavior. Physiol Behav 1985;35:255–259.
21.
Kakeyama M, Yamanouchi K: Lordosis in male rats: The facilitatory efffect of mesencephalic dorsal raphe nucleus lesion. Physiol Behav 1992;51:181–184.
22.
Arendash GW, Gorski RA: Suppression of lordotic responsiveness in the female rat during mesencephalic electrical stimulation. Pharmacol Biochem Behav 1983;19:351–357.
23.
Kakeyama M, Yamanouchi K: Female sexual behaviors in male rats with dorsal raphe nucleus lesions: Treatment with p-chlorophenylalanine. Brain Res Bull 1993;30:705–709.
24.
Alves SE, Weiland NG, Hayashi S, McEwen BS: Immunocytochemical localization of nuclear estrogen receptors and progestin receptors within the rat dorsal raphe nucleus. J Comp Neurol 1998;391:322–334.
25.
Zasorin NL: Suppression of lordosis in the hormone-primed female hamster by electrical stimulation of the septal area. Physiol Behav 1975;14:595–599.
26.
Sakuma Y: Brain control of female sexual behavior; in Yokohama Y (ed): Brain Control of the Reproductive System. Tokyo, Japan Scientific Society Press, 1992, pp 141–163.
27.
Pfaff D, Keiner M: Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J Comp Neurol 1973;151:121–158.
28.
Yamanouchi K: Inhibitory and facilitatory neural mechanisms involved in the regulation of lordosis behavior in female rats: Effects of dual cuts in the preoptic area and hypothalamus. Physiol Behav 1980;25:721–725.
29.
Timothy RK, Nance AW: The efffect of unilateral frontolateral hypothalamic knife cuts and asymmetrical unilateral septal lesions on lordosis behavior of rats. Physiol Behav 1985;35:955–595.
30.
Risold PY, Swanson LW: Connections of the lateral septal complex. Brain Res Rev 1997;24:115–195.
31.
Staiger JF, Nürnberger F: The efferent connections of the lateral septal nucleus in the guinea pig: Projections to the diencephalon and brainstem. Cell Tissue Res 1991;264:391–413.
32.
Chen TJ, Chang HC, Hsu C, Peng MT: Effects of anterior roof deafferentation on lordosis behavior and estrogen receptors in various brain regions of female rats. Physiol Behav 1992;52:7–11.
33.
Kondo Y, Yamanouchi K, Arai Y: p-Chlorophenylalanine facilitates copulatory behavior in septal lesioned but not in preoptic lesioned male rats. J Neuroendocrinol 1993;5:629–633.
34.
Dornan WA, Akesson TR, Micevych PE: A substance P projection from the VMH to the dorsal midbrain central gray: Implication for lordosis. Brain Res Bull 1990;25:791–796.
35.
Sakuma Y, Pfaff DW: Mesencephalic mechanisms for integration of female reproductive behavior in the rats. Am J Physiol 1980;237:R285–R290.
36.
Yamanouchi K, Arai Y: Lordosis-inhibiting pathway in the lateral hypothalamus: Medial forebrain bundle transection. Zool Sci 1989;6:141–145.
37.
Modianos DT, Delia H, Pfaff DW: Lordosis in female rats following medial forebrain bundle lesions. Physiol Behav 1976;18:135–141.
38.
Yamanouchi K, Arai Y: Female lordosis pattern in the male rat induced by estrogen and progesterone: Effect of interruption of the dorsal inputs to the preoptic area and hypothalamus. Endocrine J 1975;243–246:1975.
39.
Kuiper GGJM, Gustafsson JÅ: The novel estrogen receptor-beta subtype: Potential role in the cell- and promoter-specific actions of estrogen and anti-estrogen. FEBS Lett 1997;410:87–90.
40.
Miyakawa M, Arai Y: Synaptic plasticity to estrogen in the lateral septum of the adult male and female rats. Brain Res 1987;436:184–188.
41.
Parent A, Descarries L, Beaudet A: Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3H]5-hydroxytryptamine. Neuroscience 1981;6:115–138.
42.
Canteras NS, Simerly RB, Swanson LW: Organization of projections from the ventromedial nucleus of the hypothalamus: A phaseolus vulgaris-leucoagglutinin study in the rat. J Comp Neurol 1994;348:41–79.
43.
Kakeyama M, Yamanouchi Y: Inhibitory effect of baclofen on lordosis in female and male rats with dorsal raphe nucleus lesion or septal cut. Neuroendocrinology 1996;63:290–296.
44.
Herbison AE, Fénelon VS: Estrogen regulation of GABAA receptor subunit mRNA expression in preoptic area and bed nucleus of the stria terminalis of female rat brain. J Neurosci 1995;15:2328–2337.
45.
Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 2. New York, Academic Press, 1986.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
